Many private-credit fund managers are playing down their exposure to software as fears spread about threats from artificial intelligence. A detailed analysis revealed four large funds marketed to ...

Major software stocks like Microsoft, Oracle, and Salesforce have seen significant declines from their recent highs. Analysts are divided on whether the selloff is due to fears that AI will make ...

Software from Rovaniemi, Finland—building reliable products under Arctic skies, inspired by Lapland’s cold, reindeer trails, and the northern lights. Based in Rovaniemi, Finland—shipping reliable ...

Trividia Health, Inc., has issued an Urgent Medical Device Correction regarding a specific displayed error message on TRUE METRIX brand glucose meters. The “E-5 ...

Software stocks have been hammered as fears of AI proliferation take hold. This provides a compelling opportunity for savvy investors. By Danny Vena, CPA – Feb 14, 2026 at 3:02AM EST AI start-up ...

The U.S. Food & Drug Administration announced that a glucose meter (a.k.a. a blood sugar meter) company is issuing an important correction for its blood glucose monitoring system. True Metrix is the ...

Monitoring blood sugar levels is a matter of life and death for some people, which is why it’s so important to not only have a functioning blood glucose meter, but also to understand exactly how it ...

After more than 11 years of injuries and a death, the manufacturer of blood glucose monitors has issued a correction to the instructions directing actions when the glucose might be dangerously high.

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

WASHINGTON, D.C. — Diabetes patients who use certain TRUE METRIX blood glucose meters are being urged to review updated safety instructions after manufacturer ...

New AI tools from Anthropic sparked a broad sell-off in software and data stocks. Executives say fears are overblown, but analysts warn of margin and pricing pressure. Investors are reassessing which ...